Skip to main content

Table 3 Patient anticoagulation status

From: Impact of a novel protocol for atrial fibrillation management in outpatient gastrointestinal endoscopic procedures: a retrospective cohort study

  Pre-intervention Intervention p-value
Patients CHA2DS2VASc ≥ 2 92 (84.4%) 118 (83.7%) 0.89
Patients with CHA2DS2VASc ≥ 2 on anticoagulation 66 (71.7%) 90 (76.3%) 0.20
Newly diagnosed AF and CHADS2VASc ≥ 2 6 (75.0%) 12 (80.0%) 0.79
Newly diagnosed AF and CHA2DS2VASc ≥ 2 on anticoagulation 4 (66.7%) 6 (50.0%) 0.53
  1. CHA2DS2VASc congestive heart failure, hypertension, age, diabetes, stroke/transient ischemic attack/thromboembolism, vascular disease, age 65–75 years, sex category. Values are mean ± standard deviation for continuous data and n (%) for categorical data